Klivira
Request demo

Streamlining Medicare Breztri Prior Authorization Workflows

Navigating the complexities of Medicare Breztri prior authorization is a critical operational challenge for revenue cycle and prior authorization teams. Klivira provides a robust solution to automate and accelerate this process.

Breztri (budesonide, glycopyrrolate, and formoterol fumarate) is a high-volume prior authorization target across various payer types, including Medicare. For healthcare organizations managing patients with Chronic Obstructive Pulmonary Disease (COPD), optimizing the Medicare Breztri prior authorization workflow is essential to minimize delays and ensure timely access to prescribed therapies.

Understanding Breztri for Medicare Patients

Breztri is a triple combination inhaled corticosteroid (ICS), long-acting muscarinic antagonist (LAMA), and long-acting beta-agonist (LABA) indicated for the maintenance treatment of patients with COPD. As a key therapeutic option for adults with COPD, securing timely prior authorization under Medicare is vital for patient care continuity and revenue integrity.

Medicare Prior Authorization Landscape for Breztri

Prior authorization requirements for Breztri under Medicare vary significantly based on the specific Medicare program. Original Medicare (Parts A and B) has a limited scope for prior authorization, primarily for specific medical services. However, Breztri, as a pharmacy benefit, typically falls under Medicare Part D plans, which are administered by commercial insurers and have broader prior authorization requirements based on their approved formularies.

Navigating Medicare Part D Formularies and Step Therapy

For Medicare Part D beneficiaries, Breztri prior authorization is determined by the individual plan's formulary, which outlines covered drugs, their tiers, and any utilization management requirements like step therapy or quantity limits. Part D plans administer pharmacy PA per CMS-approved plan formularies and step-therapy protocols. Klivira's platform integrates with these diverse Part D plan requirements to streamline submission and tracking.

Policy Adherence: NCDs and LCDs for Breztri Coverage

While Breztri primarily falls under Part D, coverage criteria are often informed by broader Medicare policies. CMS publishes National Coverage Determinations (NCDs), and Medicare Administrative Contractors (MACs) publish Local Coverage Determinations (LCDs) for their respective jurisdictions. Accurate citations referencing the specific NCD number or LCD ID, MAC jurisdiction, and effective date are crucial for demonstrating medical necessity and securing approvals.

Klivira's Approach to Medicare Breztri PA Automation

Klivira automates the submission process for Medicare Breztri prior authorizations by connecting directly with payer portals and leveraging ePA channels where available. For situations requiring Traditional Medicare PA, Klivira's MAC-aware routing handles per-jurisdiction submission specifics, ensuring adherence to the unique requirements of contractors like Noridian, NGS, WPS, Palmetto, FCSO, and Novitas. Our platform integrates NCD/LCD-aware policy logic to guide documentation and submission.

Optimizing Documentation for Medicare Breztri Approvals

Successful Medicare Breztri prior authorization hinges on comprehensive and clinically robust documentation. This includes clear evidence of diagnosis, previous treatment failures (for step therapy), and justification for medical necessity in accordance with NCDs, LCDs, and specific Part D plan criteria. Klivira's EMR integration facilitates the automatic extraction and assembly of required clinical data, reducing manual effort and potential for errors.

Frequently asked questions

Does Original Medicare require prior authorization for Breztri?

Original Medicare (Parts A and B) has a limited scope for prior authorization, primarily for specific medical services. Breztri, as a prescription drug, typically falls under Medicare Part D plans, which are administered by private insurers and have their own prior authorization requirements.

How do Medicare Part D plans handle Breztri prior authorization?

Medicare Part D plans, operated by commercial insurers, administer pharmacy prior authorization for Breztri according to their CMS-approved formularies and step-therapy protocols. Requirements vary by plan, including specific clinical criteria, quantity limits, and preferred drug lists.

What are NCDs and LCDs, and how do they apply to Breztri?

National Coverage Determinations (NCDs) are national policies published by CMS, while Local Coverage Determinations (LCDs) are issued by Medicare Administrative Contractors (MACs) for their jurisdictions. These policies outline medical necessity criteria. While Breztri is a Part D drug, the underlying medical condition (COPD) and related services may be subject to NCDs/LCDs that inform overall coverage decisions.

Which MACs handle Traditional Medicare prior authorizations?

Where Traditional Medicare requires prior authorization, submissions route through the responsible Medicare Administrative Contractor (MAC) for the provider's jurisdiction. Key MACs include Noridian, NGS, WPS, Palmetto, FCSO, and Novitas.

How does Klivira support Breztri prior authorization for Medicare?

Klivira automates Breztri prior authorization by integrating with EMRs, routing submissions through MAC-jurisdiction channels for Original Medicare, and connecting with Part D plan portals. Our platform incorporates NCD/LCD-aware policy logic to streamline documentation and accelerate approvals for Medicare beneficiaries.

Related coverage

Other breztri prior authorization by payer

Other breztri prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo